Group One Trading’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$65.6M Buy
138,600
+86,700
+167% +$43.6M 0.13% 148
2025
Q4
$24.2M Buy
51,900
+43,700
+533% +$20.3M 0.04% 438
2025
Q3
$3.49M Sell
8,200
-42,900
-84% -$16.6M 0.01% 1808
2025
Q2
$19.6M Sell
51,100
-1,400
-3% -$504K 0.04% 442
2025
Q1
$18.1M Buy
52,500
+26,900
+105% +$8.65M 0.05% 355
2024
Q4
$7.68M Buy
25,600
+7,300
+40% +$2.55M 0.02% 860
2024
Q3
$7.44M Buy
18,300
+400
+2% +$146K 0.02% 758
2024
Q2
$5.75M Buy
17,900
+100
+0.6% +$32.5K 0.02% 722
2024
Q1
$5.94M Sell
17,800
-24,500
-58% -$7.49M 0.02% 728
2023
Q4
$11.4M Buy
42,300
+4,900
+13% +$1.21M 0.03% 627
2023
Q3
$9.2M Sell
37,400
-17,500
-32% -$4.79M 0.03% 568
2023
Q2
$16.7M Buy
54,900
+19,600
+56% +$5.45M 0.05% 299
2023
Q1
$9.31M Sell
35,300
-12,300
-26% -$3.12M 0.03% 506
2022
Q4
$11.4M Sell
47,600
-66,400
-58% -$14.9M 0.03% 662
2022
Q3
$21M Sell
114,000
-20,100
-15% -$4M 0.04% 377
2022
Q2
$22.5M Buy
134,100
+117,100
+689% +$25.2M 0.04% 425
2022
Q1
$4.26M Sell
17,000
-75,400
-82% -$18.9M ﹤0.01% 1681
2021
Q4
$23.7M Sell
92,400
-38,500
-29% -$9.42M 0.02% 600
2021
Q3
$31.8M Buy
130,900
+68,900
+111% +$16.8M 0.03% 413
2021
Q2
$12.8M Buy
62,000
+37,700
+155% +$7.68M 0.02% 903
2021
Q1
$4.58M Sell
24,300
-19,800
-45% -$3.49M 0.01% 1599
2020
Q4
$7.25M Sell
44,100
-3,500
-7% -$512K 0.01% 1024
2020
Q3
$5.93M Buy
47,600
+16,600
+54% +$2.05M 0.02% 814
2020
Q2
$3.01M Buy
31,000
+3,100
+11% +$322K 0.01% 1172
2020
Q1
$2.51M Buy
27,900
+26,400
+1,760% +$3.42M 0.02% 896
2019
Q4
$222K Sell
1,500
-12,000
-89% -$1.61M ﹤0.01% 3092
2019
Q3
$1.63M Buy
13,500
+7,000
+108% +$905K 0.01% 1365
2019
Q2
$879K Buy
6,500
+6,000
+1,200% +$759K 0.01% 1687
2019
Q1
$65K Sell
500
-4,600
-90% -$618K ﹤0.01% 3440
2018
Q4
$635K Hold
5,100
0.01% 1839
2018
Q3
$710K Sell
5,100
-3,000
-37% -$373K 0.01% 1975
2018
Q2
$831K Sell
8,100
-100
-1% -$10.1K 0.01% 1881
2018
Q1
$795K Sell
8,200
-36,400
-82% -$3.53M 0.01% 1682
2017
Q4
$3.92M Sell
44,600
-17,900
-29% -$1.44M 0.03% 778
2017
Q3
$4.97M Buy
62,500
+35,900
+135% +$2.89M 0.05% 512
2017
Q2
$2.32M Buy
26,600
+12,400
+87% +$1.05M 0.02% 867
2017
Q1
$1.26M Sell
14,200
-42,600
-75% -$3.55M 0.01% 1175
2016
Q4
$4.2M Sell
56,800
-43,900
-44% -$3.29M 0.04% 506
2016
Q3
$7.62M Buy
100,700
+18,300
+22% +$1.4M 0.08% 263
2016
Q2
$6.35M Buy
82,400
+15,500
+23% +$1.22M 0.08% 299
2016
Q1
$5.22M Sell
66,900
-86,800
-56% -$6.06M 0.07% 326
2015
Q4
$10.4M Buy
153,700
+400
+0.3% +$27.9K 0.12% 165
2015
Q3
$11.9M Buy
153,300
+22,000
+17% +$1.95M 0.16% 114
2015
Q2
$11.9M Buy
131,300
+24,900
+23% +$1.99M 0.17% 107
2015
Q1
$8M Sell
106,400
-31,500
-23% -$2.26M 0.13% 141
2014
Q4
$10.1M Buy
137,900
+43,200
+46% +$3.04M 0.15% 117
2014
Q3
$6.68M Sell
94,700
-2,700
-3% -$178K 0.1% 209
2014
Q2
$5.49M Sell
97,400
-3,700
-4% -$195K 0.08% 260
2014
Q1
$5.31M Sell
101,100
-89,500
-47% -$4.45M 0.09% 204
2013
Q4
$9.09M Buy
190,600
+59,500
+45% +$2.75M 0.14% 125
2013
Q3
$5.61M Buy
131,100
+71,200
+119% +$2.78M 0.11% 185
2013
Q2
$2.16M Buy
+59,900
New +$2.32M 0.05% 385

Other funds holding HCA

Group One Trading's HCA Position: Q2 2025 in Review

Group One Trading sold out of HCA Healthcare (HCA) in Q2 2025, closing a stake of 5,243 shares — an estimated $1.89M sold.

Group One Trading first reported a position in HCA in Q2 2013 and held it in 24 quarters. The position peaked at $8.28M in Q4 2022. 1,248 funds tracked by Wall St. Rank hold HCA as of Q2 2025.

  • Group One Trading reported no remaining HCA Healthcare position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 5,243 HCA Healthcare shares in Q2 2025, an estimated $1.89M.
  • Group One Trading first reported a position in HCA Healthcare in Q2 2013 and held it in 24 quarters.
  • Group One Trading's HCA Healthcare position peaked at $8.28M in Q4 2022.
  • 1,248 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.